
VIDEO: Neurotech prepares to launch Encelto for macular telangiectasia type 2
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Richard Small, CEO of Neurotech Pharmaceuticals, provides an update on Encelto for macular telangiectasia type 2. Ahead of the encapsulated cell therapy’s June launch …